Cva Family Office, LLC Moderna, Inc. Transaction History

Cva Family Office, LLC

$550 Million
Q2 2024

A detailed history of Cva Family Office, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 541 shares of MRNA stock, worth $35,570. This represents 0.01% of its overall portfolio holdings.

Number of Shares

541

Previous 445 21.57%

Holding current value

$35,570

Previous $47,000 36.17%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	BUY	$101.21 - $166.61 $9,716 - $15,994	96 Added 21.57%	541 $64,000
Q1 2024 Apr 10, 2024	BUY	$85.37 - $115.44 $26,891 - $36,363	315 Added 242.31%	445 $47,000
Q4 2023 Jan 16, 2024	BUY	$69.51 - $104.43 $9,036 - $13,575	130 New	130 $12,000
Q2 2023 Jul 10, 2023	SELL	$118.5 - $160.53 $1,185 - $1,605	-10 Reduced 3.45%	280 $34,000
Q1 2023 Apr 26, 2023	SELL	$135.66 - $197.02 $8,817 - $12,806	-65 Reduced 18.31%	290 $44,000
Q4 2022 Feb 21, 2023	SELL	$118.38 - $210.04 $4,735 - $8,401	-40 Reduced 10.13%	355 $63,000
Q3 2022 Nov 22, 2022	BUY	$118.07 - $194.18 $1,180 - $1,941	10 Added 2.6%	395 $47,000
Q2 2022 Jul 11, 2022	BUY	$117.13 - $176.59 $8,784 - $13,244	75 Added 24.19%	385 $55,000
Q1 2022 Apr 22, 2022	BUY	$126.46 - $235.05 $3,161 - $5,876	25 Added 8.77%	310 $53,000
Q4 2021 Jan 25, 2022	BUY	$225.82 - $368.51 $64,358 - $105,025	285 New	285 $72,000
Q1 2021 Apr 14, 2021	SELL	$109.18 - $185.98 $43,672 - $74,392	-400 Closed	0 $0
Q4 2020 Jan 15, 2021	BUY	$65.74 - $169.86 $26,295 - $67,944	400 New	400 $41,000
Q3 2020 Oct 27, 2020	SELL	$54.34 - $94.85 $76,076 - $132,790	-1,400 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$29.67 - $80.0 $11,868 - $32,000	400 Added 40.0%	1,400 $90,000
Q1 2020 May 28, 2020	BUY	$17.78 - $31.58 $17,780 - $31,580	1,000 New	1,000 $30,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.

Account

Cva Family Office, LLC Moderna, Inc. Transaction History